HHS Calls For More Resources, Authority For Health Cybersecurity

An HHS cybersecurity official recently testified to Congress stressing HHS’ efforts to increase cybersecurity and lobbying to keep his job as an Obama-era directive is being revised by the Biden Administration. In the hearing, Republican and Democratic leaders of the House Energy & Commerce Committee found common ground around preserving the cybersecurity role of sector risk management agencies, were supportive of the work of the deputy director, and called for the continuation of his efforts in the role. Brian Mazanec,...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Secondary Author(s): 
Topics: 

Advocacy Org Warns Drug-Price Negotiations Could Hurt Patient Access

CMS’ current Medicare drug price negotiation guidance could negatively impact patient access to much-needed drugs and other forms of care, a key patient advocacy group told Inside Drug Pricing , echoing concerns from drug makers who stand ready to take legal action against CMS to stall implementation of the price negotiation process. Michael Ward, vice president of Public Policy and Government Relations for the Alliance for Aging Research, said CMS’ initial guidance published in March exacerbated the organization’s concerns that...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 05/29/2023
IDP Volume: 
Vol. 6, No. 22
Author: 
Topics: 

Stakeholders Applaud, Urge Caution As MN Moves Toward Public Option

Health care advocates applauded Minnesota’s steps toward a public option following passage of a budget bill, which Democratic Gov. Tim Waltz (D) signed Wednesday (May 24), requiring agencies to study the feasibility of public option that would be available to residents who buy individual market coverage, including undocumented residents of all ages. However, the budget language omits a provision that would allow certain small businesses to buy into the new option. Stakeholders who oppose the public option also say that...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
Author: 

Advocates Encouraged By AZ’s Initial Medicaid Disenrollment Process

Arizona has reduced its Medicaid enrollment by about 56,000 beneficiaries since April 1 as one of the first states to begin trimming Medicaid rolls, alongside heavily criticized states like Arkansas and Idaho -- yet beneficiary advocates say the southwestern state is on a much better trajectory. Five states began dropping Medicaid and Children’s Health Insurance Program enrollees in April after the maintenance of effort requirement expired and states could begin normal redeterminations following a near three-year pause due to the...
Article Type: 
Site Name: 
InsideHealthPolicy.com

Pfizer’s Paxlovid Becomes First Oral COVID-19 Drug To Get FDA Approval

FDA on Thursday (May 25) approved Pfizer’s COVID-19 drug Paxlovid -- making it the first oral antiviral pill approved to treat coronavirus in adults ages 18 and older who are at high risk for progressing to severe disease -- a little more than two months after a panel of agency advisers backed the pill while also calling for more data on so-called rebound cases of COVID-19 and urging FDA to include clear information about drug-drug interactions on the product label...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 










Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.